Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 463 participants.
Also called NCT01319812
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 463 participants
- Sponsor
- Registry
-
NCT01319812
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT01319812. Non-randomized; no masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2015-09 (actual). Results posted on 2017-06-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents
- Acronym
- BIOFLEX-I
- Condition
- Peripheral Artery Disease
- Condition
- Peripheral Vascular Disease
- Intervention (Device)
- Astron Stents
- Intervention (Device)
- Pulsar Stents
- Lead sponsor
- Biotronik, Inc.
Record details
- Record id
cardio:ct-nct01319812- Content hash
e66a9f772056416ca6d5f2fbb1020fb8a182e6e397acb2ec67037d9087bdc4a3